indianstockmarket
Home Results Stocks to Buy About Us Contact Us
 
indianstockmarket
 
ABB Limited
ACC Limited
Bajaj Auto Ltd
Bharti Airtel Limited
Bharat Heavy Electricals Ltd
Cipla Ltd
Dabur India Ltd
Dr. Reddy's Laboratories
GAIL (India) Limited
GlaxoSmithKline Ltd
Grasim Industries Ltd
Gujarat Ambuja Cement Ltd
HCL Technologies Ltd
H D F C
HDFC Bank Ltd
Hero Honda Motors Ltd
Hindalco Industries Ltd
Hindustan Lever Ltd
H P C L
ICICI Bank Ltd
Infosys Technologies Ltd
I P C L
I T C Ltd
Jet Airways (India) Ltd
Larsen & Toubro Limited
Mahindra & Mahindra Ltd
Maruti Udyog Limited
M T N L
N A L C O
Oil & Natural Gas Corpn Ltd
Oriental Bank of Commerce
Punjab National Bank
Ranbaxy Laboratories Ltd
Reliance Communications
Reliance Energy Ltd
Reliance Industries Ltd
Steel Authority of India Ltd
Satyam Computer Services
State Bank of India
Siemens Ltd
Sun Pharmaceuticals
Suzlon Energy Ltd
Tata Motors Limited
Tata Power Co. Ltd
Tata Steel Limited
Tata Consultancy Services
V S N L
Wipro Ltd
Zee Telefilms Ltd
Mutual Funds
 
http://mumbaibull.com
 
http://winfromus.com
 

Indian Stock Market

Indianstockmarket.net is an effort to educate indian investor by providing useful stock news, stock market websites, informative articles, resources to various investment guides.
Tue, 31 Aug 2010 12:35:23 -0700

Sun's Cranbury plant warned for flouting manufacturing code
Sun Pharmaceutical Industries' wholly-owned subsidiary in the US has received a warning letter from the US Food and Drug Administration (USFDA).
Wed, 01 Sep 2010 09:03:44 -0700

Lilly wins ban on generic Strattera
Court order prohibits alternative attention-deficit treatments until patent appeal is decided.
Wed, 01 Sep 2010 09:05:35 -0700

Lilly wins generic Strattera delay
Eli Lilly and Co., the world's biggest maker of psychiatric drugs, has won a court order banning generic versions of the attention-deficit treatment Strattera until a patent appeal is decided.
Tue, 31 Aug 2010 20:38:43 -0700

Lilly wins ban of generic Strattera pending appeal
The U.S. Court of Appeals for the Federal Circuit in Washington on Tuesday granted Lilly's request to prevent sales until the court rules on a judge's decision invalidating a patent on the medicine.
Tue, 31 Aug 2010 12:29:21 -0700

CORPORATE
ALLIANCES & JOINT VENTURES: Honda, Hero group divorce reports gain momentum Tuesday saw yet another round of denials from the Hero group and Honda of Japan to reports that they were parting ways. India Inc is, however, convinced that the divorce ...
Tue, 31 Aug 2010 09:29:22 -0700

Intellectual Property
31 Aug 2010 - United States - Intellectual Property - IP Update, August 2010 - Part 1 - McDermott Will & Emery - The U.S. Court of Appeals for the Federal Circuit expressed its belief in the continued validity of its machine-or-transformation test in wake of the Supreme Court’s Bilski decision, but left the fight for the patent eligibility of medical treatment claims for another day. King ...
Thu, 26 Aug 2010 20:44:51 -0700

Lilly wins further delay in sales of Strattera copies
Strattera generated U.S. sales of $445.6 million last year, and each day that Lilly can fend off generic competition would translate into an average $1.22 million in sales.
 
Tue, 31 Aug 2010 15:59:36 GMT+00:00


Moneycontrol.com

Sun Pharmaceutical Unit Gets FDA Warning
Wall Street Journal
BANGALORE—Sun Pharmaceutical Industries Ltd. said Tuesday that its wholly owned US unit, Sun Pharmaceutical Industries Inc., ...
Sun Pharma gets FDA approval for hyperactivity disorder capsulesMoneylife Personal Finance Magazine
Sun Pharma gets USFDA nod for Strattera® capsulesHindu Business Line
Sun Pharma gets second warning letter from FDALivemint
domain-B -Economic Times -India Infoline.com
all 57 news articles »
Fri, 03 Sep 2010 12:43:53 GMT+00:00


Sun Pharma: Gets FDA approval for new drug
Healthcare Digital (press release)
Leading drug manufacturer, Sun Pharmaceutical Industries, has announced that it has received approval from the US Food and Drug Administration (FDA) to sell ...

and more »
Fri, 03 Sep 2010 15:20:43 GMT+00:00


Obviousness-type double patenting analysis for patents claiming a compound ...
Lexology (registration)
In 2006, generic drug manufacturer Sun Pharmaceutical Industries, Ltd. (“Sun”) filed an ANDA with the FDA seeking approval to market a generic version of ...

and more »
Thu, 26 Aug 2010 06:50:54 GMT+00:00


Sun Pharma Challenges Wockhardt Settlement With Lenders
RTT News
(RTTNews) - Sun Pharmaceutical Industries Ltd., has challenged a settlement arrived at between Wockhardt Ltd., and some of its lenders, say reports. ...

and more »
Mon, 23 Aug 2010 11:06:59 GMT+00:00


Taro Provides Preliminary First Half 2010 Financial Results
MarketWatch (press release)
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the ...
Taro Pharmaceutical reports (unaudited) growthGlobes

all 15 news articles »
Wed, 01 Sep 2010 02:10:07 GMT+00:00


Adani Power, Indian Oil Corp., Kingfisher Airlines: India Equity Preview
Bloomberg
Sun Pharmaceutical Industries Ltd. (SUNP IN): The drugmaker said it has taken immediate corrective actions after receiving a warning letter from the US Food ...

and more »
Thu, 02 Sep 2010 17:13:06 GMT+00:00


Sun Pharmaceutical Industries - More trouble with the USFDA - PINC Event Update
Equity Bulls
Sun Pharma (SUNP) has reported that its facility in Cranbury, New Jersey received a warning letter on August 25th, 2010. This facility does not meaningfully ...

 
Directory | Disclaimer
 
Developed by WorldITLab.
 
Copyright © 2004 - 2007 indianstockmarket.net . All rights reserved worldwide.
 
Content by Stock Market Guide